ArticleWorld journal of surgical oncology2025
A novel approach for benign parotid tumors: a dual-focused strategy on functional preservation and aesthetics.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Autologous Fat Graft Combined With Botulinum Toxin A Injection for Facial Sunken Deformity Treatment: A Retrospective Clinical Analysis.Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveBenign tumors of the parotid gland are the most common salivary gland diseases, Conventional parotid surgery often leads to various complications that severely affect the postoperative quality of life of patients.
methodsThis study included 400 patients with clinically benign tumors in the tail of the parotid gland, divided into two groups: one group received the classical surgical method, and the other group received the new surgical method.Through postoperative follow-up, the differences in postoperative quality of life between the two groups were compared by recording the incidence of temporary facial paralysis, facial depression deformity, scar satisfaction, and Frey's syndrome.
resultsThe new surgical group demonstrated a marked reduction in subjective Frey's syndrome incidence (12 cases [6%] vs. 24 cases [12%] in 200 patients). The new surgical group also exhibited significantly reduced postoperative drainage volume, intraoperative blood loss hospital stay duration, and extubation time, collectively indicating its less invasive nature.Notably, the new surgical group achieved superior facial nerve function outcomes, with significantly lower postoperative facial nerve function scores (1.29 ± 0.16 vs. 2.15 ± 0.28, P < 0.05),. Additionally, the new technique group showed a marked reduction in facial depression deformity scores (0.59 ± 0.16 vs. 1.15 ± 0.48, P < 0.05). Regarding aesthetic outcomes, the new approach achieved higher patient satisfaction (90% vs. 70%, P < 0.05), further underscoring its clinical advantages.
conclusionThe new surgical method proposed in this article for benign tumors of the parotid gland can effectively reduce complications and improve the quality of life of patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.